Furthermore, it is worth mentioning that we investigated the FGF2 levels at Kasai procedure, while studies reporting on high FGF levels in BA infants exclusively focus on the post-Kasai follow-ups [25]. The gene discussed is FGF2; the disease is breast angiosarcoma.